AAAAAA

   
Results: 1-10 |
Results: 10
Lacryglobin in human tears, a potential marker for cancer
Authors: Evans, V Vockler, C Friedlander, M Walsh, B Willcox, MDP
Citation: V. Evans et al., Lacryglobin in human tears, a potential marker for cancer, CLIN EXP OP, 29(3), 2001, pp. 161-163
Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs
Authors: Switzer, WM Michler, RE Shanmugam, V Matthews, A Hussain, AI Wright, A Sandstrom, P Chapman, LE Weber, C Safley, S Denny, RR Navarro, A Evans, V Norin, AJ Kwiatkowski, P Heneine, W
Citation: Wm. Switzer et al., Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs, TRANSPLANT, 71(7), 2001, pp. 959-965
Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients
Authors: Casassus, P Gibson, J Joshua, DE Matthews, J Diaz, JC Gertz, MA Kyle, R Leong, T Oken, MM Fritz, E Ludwig, H Corrado, C Lastiri, F Peest, D Grosbois, B Vela-Ojeda, J Avvisati, G Mandelli, F Petrucci, MT Capnist, G Child, JA Drayson, MT Dunn, J MacLennan, I Mellstedt, H Osterborg, A Rodjer, S Turesson, I Westin, J Bergsagel, D Browman, GP Shustik, C Zee, B Hjorth, M Holmberg, E Rodjer, S Turesson, I Westin, J Alison, R Clarke, M Elphinstone, P Evans, V Gray, R Hicks, C James, S MacKinnon, L Peto, R Richards, S Wheatley, K Blade, J Fontanillas, M San Miguel, J Aitchison, R Newland, AC Cunningham, D Malpas, J Powles, RL Montuoro, A Jacobson, J Salmon, S
Citation: P. Casassus et al., Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients, BR J HAEM, 113(4), 2001, pp. 1020-1034
Modulation of tear film protein secretion with phosphodiesterase inhibitors
Authors: Evans, V Willcox, MDP Millar, TJ
Citation: V. Evans et al., Modulation of tear film protein secretion with phosphodiesterase inhibitors, CLIN EXP OP, 28(3), 2000, pp. 208-211
Targeting the Hprt locus in mice reveals differential regulation of Tie2 gene expression in the endothelium
Authors: Evans, V Hatzopoulos, A Aird, WC Rayburn, HB Rosenberg, RD Kuivenhoven, JA
Citation: V. Evans et al., Targeting the Hprt locus in mice reveals differential regulation of Tie2 gene expression in the endothelium, PHYSIOL GEN, 2(2), 2000, pp. 67-75
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
Authors: Dalesio, O van Tinteren, H Clarke, M Peto, R Schroder, FH Dechering, I Evans, V Godwin, J Blumenstein, BA Crawford, ED Denis, L Hall, R Hill, C Iversen, P Shipley, WU Soloway, M Sylvester, R
Citation: O. Dalesio et al., Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials, LANCET, 355(9214), 2000, pp. 1491-1498
Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials
Authors: Hehlmann, R Heimpel, H Hasford, J Allan, N Burnett, A Shepherd, P Oberg, G Simonsson, B Stromberg, U Alison, R Clarke, M Evans, V Godwin, J MacKinnon, E Richards, S
Citation: R. Hehlmann et al., Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials, BR J HAEM, 110(3), 2000, pp. 573-576
Chemotherapeutic options in chronic lymphocytic leukemia: A meta-analysis of the randomized trials
Authors: Geisler, C Hansen, MM Yeap, BY Wiernik, P Binet, JL Chastang, C Dighiero, G Travade, P Jaksic, B Brugiatelli, M Kimby, E Catovsky, D Hamblin, T Richards, S Bosch, F Fontanillas, M Montserrat, E Alison, R Clarke, M Duong, H Elphinstone, P Evans, V Godwin, J Gray, R Greaves, E Hicks, C James, S Mead, G Peto, R Richards, S Wheatley, K
Citation: C. Geisler et al., Chemotherapeutic options in chronic lymphocytic leukemia: A meta-analysis of the randomized trials, J NAT CANC, 91(10), 1999, pp. 861-868
A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influenceof side-effects and administration attributes
Authors: Young, A Topham, C Moore, J Turner, J Wardle, J Downes, M Evans, V Kay, S
Citation: A. Young et al., A patient preference study comparing raltitrexed ('Tomudex') and bolus or infusional 5-fluorouracil regimens in advanced colorectal cancer: influenceof side-effects and administration attributes, EUR J CA C, 8(3), 1999, pp. 154-161
Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials
Authors: Pasquali, S Maqueo, JD Vela, J Kyle, RA Leong, T Fritz, E Suciu, S Palva, IP Oivanen, T Corrado, C Lastiri, FJ Peest, D Kildahl-Andersen, O Maniatis, A Alison, R Clarke, M Evans, V Gray, R Greaves, E Hall, E Hicks, C James, S Peto, R Richards, S Sinclair, D Tooth, A Wheatley, K Avvisati, G Boccadoro, M Bugliosi, R Mandelli, F Petrucci, MT Pileri, A Tribalto, M Alexanian, R Delasalle, KB Child, J Dunn, J MacLennan, I Milligan, D Mellstedt, H Osterborg, A Hjorth, M Holmberg, E Rodjer, S Westin, J Kamiya, O Shimizu, K Bergsagel, DE Shustik, C Hippe, E Kjaersgaard, E Turesson, I Westin, J Riccardi, A Ucci, G Blade, J Fontanillas, M De Rosa, L Montuoro, A Bartolucci, AA Omura, GA Stagg, M Salmon, S Tangen, C Jacobs, P Wood, L Levy, LM
Citation: S. Pasquali et al., Combination chemotherapy versus melphalan plus prednisone as treatment formultiple myeloma: An overview of 6,633 patients from 27 randomized trials, J CL ONCOL, 16(12), 1998, pp. 3832-3842
Risultati: 1-10 |